PGHL
Procter & Gamble Health Limited
Each stock's 10,000-path forecast, rendered as light.
Procter & Gamble Health Limited (PGHL) Stock Analysis & Case Study
Is PGHL a good buy? The data-driven verdict.
Procter & Gamble Health Limited (PGHL) trades at ₹6,068,on the numbers it worth a closer look, a Downstox Snapshot Score of 62/100.
On the numbers, Procter & Gamble Health Limited (PGHL) worth a closer look, a Downstox Snapshot Score of 62/100, weighing premium at 30.3× earnings, ROE of 61.6%, a 58% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
PGHL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How PGHL ranks against the 2,373 companies in our screener
- PGHL's market cap of 10,199 Cr ranks in the 76th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PGHL's book value of ₹316 ranks in the 82nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PGHL's promoter holding of 51.8% ranks in the 35th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PGHL's 3-year profit (PAT) growth of 19.0% ranks in the 55th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PGHL's 3-year revenue growth of 8.0% ranks in the 44th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PGHL's debt-to-equity ratio of 0.02x is lower than 94% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is PGHL overvalued? PGHL P/E vs peers
PGHL trades at 30.3× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
PGHL share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of PGHL history (22%/yr drift, 25%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| PGHL 2027 | ₹4,679 | ₹6,472 | ₹8,951 | +5% |
| PGHL 2028 | ₹4,292 | ₹6,817 | ₹10,828 | +11% |
| PGHL 2029 | ₹4,077 | ₹7,180 | ₹12,644 | +17% |
| PGHL 2030 | ₹3,944 | ₹7,563 | ₹14,501 | +23% |
| PGHL 2031 | ₹3,818 | ₹7,966 | ₹16,620 | +30% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability PGHL goes up, or doubles?
The bull case for PGHL
- PGHL's return on equity of 61.6% ranks in the top 1% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PGHL's return on capital employed of 83.5% ranks in the top 1% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- PGHL's dividend yield of 2.5% ranks in the 91st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹12,644.
The bear case & risks
- PGHL's P/E of 30.6x is lower than 45% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 19.2× price-to-book means most of the value is intangible/expectations, not assets on the books.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹4,077.
PGHL volatility & expected range, how bumpy is the ride?
Over the last 9.8 years PGHL compounded at 22%/year with annualized volatility of 25%. That volatility implies a 1-year 80% range of ₹4,679-₹8,951, the honest backbone behind any single price target.
PGHL price forecast, the full 60-month probability fan
PGHL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds PGHL hits common targets within the simulated horizon?
Full multi-horizon detail on the PGHL price target & forecast page.
PGHL Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. PGHL scores 6/8, mixed financial health.
PGHL MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy PGHL with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| Zerodha | 27.52% | 3.6× |
| Groww | 27.53% | 3.6× |
| Dhan | 27.52% | 3.6× |
| Kotak Neo | 30.03% | 3.3× |
| Paytm Money | 27.53% | 3.6× |
| Pocketful | 27.35% | 3.7× |
| Fyers | 27.78% | 3.6× |
| Anand Rathi | 27.52% | 3.6× |
| Bajaj Broking | 28.00% | 3.6× |
| Share IndiaCHEAPEST | 27.18% | 3.7× |
Compare every broker on the PGHL MTF page.
About Procter & Gamble Health Limited: sector, index & market-cap context
Procter & Gamble Health Limited (PGHL) is a small-cap NSE-listed company, with a market capitalisation of ₹10,082 Cr. See more stocks on our screener.
How the PGHL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Procter & Gamble Health Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
PGHL analysis, FAQs
Is Procter & Gamble Health Limited (PGHL) a good buy?
On the numbers, Procter & Gamble Health Limited (PGHL) worth a closer look, a Downstox Snapshot Score of 62/100, weighing premium at 30.3× earnings, ROE of 61.6%, a 58% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is PGHL overvalued or undervalued?
PGHL trades at 30.3× earnings, premium versus the ~22× long-run Nifty average.
What is the PGHL share price target for 2031?
PGHL's probability-weighted 2031 median target is ₹7,966, with an 80% range of ₹3,818-₹16,620 (10,000-path Monte-Carlo).
What is the probability PGHL doubles in 5 years?
The modelled probability of PGHL reaching ₹12,289 (2×) within 5 years is 23%.
What is the bull case for PGHL?
PGHL's return on equity of 61.6% ranks in the top 1% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. PGHL's return on capital employed of 83.5% ranks in the top 1% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. PGHL's dividend yield of 2.5% ranks in the 91st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in PGHL?
PGHL's P/E of 30.6x is lower than 45% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 19.2× price-to-book means most of the value is intangible/expectations, not assets on the books.